207 related articles for article (PubMed ID: 19445675)
1. Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia.
Cerveira N; Santos J; Bizarro S; Costa V; Ribeiro FR; Lisboa S; Correia C; Torres L; Vieira J; Snijder S; Mariz JM; Norton L; Mellink CH; Buijs A; Teixeira MR
BMC Cancer; 2009 May; 9():147. PubMed ID: 19445675
[TBL] [Abstract][Full Text] [Related]
2. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).
Cerveira N; Correia C; Bizarro S; Pinto C; Lisboa S; Mariz JM; Marques M; Teixeira MR
Oncogene; 2006 Oct; 25(45):6147-52. PubMed ID: 16682951
[TBL] [Abstract][Full Text] [Related]
3. A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review.
van Binsbergen E; de Weerdt O; Buijs A
Cancer Genet Cytogenet; 2007 Jul; 176(1):72-5. PubMed ID: 17574968
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.
Santos J; Cerveira N; Bizarro S; Ribeiro FR; Correia C; Torres L; Lisboa S; Vieira J; Mariz JM; Norton L; Snijder S; Mellink CH; Buijs A; Shih LY; Strehl S; Micci F; Heim S; Teixeira MR
Leuk Res; 2010 May; 34(5):615-21. PubMed ID: 19748670
[TBL] [Abstract][Full Text] [Related]
5. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
[TBL] [Abstract][Full Text] [Related]
6. A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome.
Cerveira N; Santos J; Pinheiro M; Snijder S; van der Lelie H; Mellink CH; Teixeira MR
Cancer Genet Cytogenet; 2008 Aug; 185(1):62-4. PubMed ID: 18656699
[No Abstract] [Full Text] [Related]
7. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
Zhang LJ; Lu XL; He J; Li Y
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
9. Structural and expression changes of septins in myeloid neoplasia.
Cerveira N; Santos J; Teixeira MR
Crit Rev Oncog; 2009; 15(1-2):91-115. PubMed ID: 20136629
[TBL] [Abstract][Full Text] [Related]
10. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation.
Tang G; DiNardo C; Zhang L; Ravandi F; Khoury JD; Huh YO; Muzzafar T; Medeiros LJ; Wang SA; Bueso-Ramos CE
Hum Pathol; 2015 Jan; 46(1):65-73. PubMed ID: 25387813
[TBL] [Abstract][Full Text] [Related]
11. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related acute myeloid leukemia 6 years after clonal detection of inv(11)(q21q23) and MLL gene rearrangement.
Takei N; Suzukawa K; Mukai HY; Itoh T; Okoshi Y; Yoda Y; Nagasawa T
Int J Hematol; 2006 Apr; 83(3):247-51. PubMed ID: 16720556
[TBL] [Abstract][Full Text] [Related]
13. A MLL-KIAA0284 fusion gene in a patient with secondary acute myeloid leukemia and t(11;14)(q23;q32).
Burmeister T; Meyer C; Thiel G; Reinhardt R; Thiel E; Marschalek R
Blood Cells Mol Dis; 2008; 41(2):210-4. PubMed ID: 18640063
[TBL] [Abstract][Full Text] [Related]
14. MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities.
Park TS; Lee ST; Song J; Lee KA; Lee SG; Kim J; Suh B; Kim SJ; Lee JH; Park R; Choi JR
Cancer Genet Cytogenet; 2008 Nov; 187(1):50-3. PubMed ID: 18992643
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers for MLL-translocated acute myeloid leukemia.
Lagacé K; Barabé F; Hébert J; Cellot S; Wilhelm BT
Exp Hematol; 2017 Dec; 56():58-63. PubMed ID: 28911906
[TBL] [Abstract][Full Text] [Related]
16. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.
Classen CF; Teigler-Schlegel A; Röttgers S; Reinhardt D; Döhner K; Debatin KM
Ann Hematol; 2005 Nov; 84(12):774-80. PubMed ID: 16044313
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
Cerveira N; Lisboa S; Correia C; Bizarro S; Santos J; Torres L; Vieira J; Barros-Silva JD; Pereira D; Moreira C; Meyer C; Oliva T; Moreira I; Martins Â; Viterbo L; Costa V; Marschalek R; Pinto A; Mariz JM; Teixeira MR
Mol Oncol; 2012 Oct; 6(5):553-64. PubMed ID: 22846743
[TBL] [Abstract][Full Text] [Related]
18. A complex t(1;22;11)(q44;q13;q23) translocation causing MLL-p300 fusion gene in therapy-related acute myeloid leukemia.
Ohnishi H; Taki T; Yoshino H; Takita J; Ida K; Ishii M; Nishida K; Hayashi Y; Taniwaki M; Bessho F; Watanabe T
Eur J Haematol; 2008 Dec; 81(6):475-80. PubMed ID: 18778367
[TBL] [Abstract][Full Text] [Related]
19. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM
Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532
[TBL] [Abstract][Full Text] [Related]
20. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
